OBJECTIVE: A cluster randomized trial was performed to evaluate an educational intervention to improve parental attitudes and vaccine uptake in vaccine-hesitant parents. METHODS: Two primary care sites were randomized to provide families with either usual care or an intervention (video and written information) for vaccine-hesitant parents. Eligible parents included those presenting for their child's 2-week well-child visit with performance on the Parent Attitudes about Childhood Vaccines (PACV) survey suggesting vaccine hesitancy (score ≥25). Enrollees completed PACV surveys at the 2-month well-child visit and vaccination status at 12 weeks of age was assessed. The primary outcome was the difference in PACV scores obtained at enrollment and 2 months between the 2 groups. The proportion of on-time vaccination was also compared at 12 weeks. RESULTS:A total of 454 parents were approached, and 369 (81.3%) participated; 132 had PACV scores of ≥25 and were enrolled, 67 in the control group (mean PACV score 37) and 55 in the intervention group (mean PACV score 40). Two-month PACV surveys were completed by 108 (∼90%) of enrollees. Parents in the intervention group had a significant decrease in PACV score at 2 months compared to control (median difference 6.7, P = .049); this remained significant after adjustment for baseline PACV score, race/ethnicity, and income (P = .044). There was no difference in the on-time receipt of vaccines between groups at 12 weeks. CONCLUSIONS: A brief educational intervention for vaccine-hesitant parents was associated with a modest but significant increase in measured parental attitudes toward vaccines.
RCT Entities:
OBJECTIVE: A cluster randomized trial was performed to evaluate an educational intervention to improve parental attitudes and vaccine uptake in vaccine-hesitant parents. METHODS: Two primary care sites were randomized to provide families with either usual care or an intervention (video and written information) for vaccine-hesitant parents. Eligible parents included those presenting for their child's 2-week well-child visit with performance on the Parent Attitudes about Childhood Vaccines (PACV) survey suggesting vaccine hesitancy (score ≥25). Enrollees completed PACV surveys at the 2-month well-child visit and vaccination status at 12 weeks of age was assessed. The primary outcome was the difference in PACV scores obtained at enrollment and 2 months between the 2 groups. The proportion of on-time vaccination was also compared at 12 weeks. RESULTS: A total of 454 parents were approached, and 369 (81.3%) participated; 132 had PACV scores of ≥25 and were enrolled, 67 in the control group (mean PACV score 37) and 55 in the intervention group (mean PACV score 40). Two-month PACV surveys were completed by 108 (∼90%) of enrollees. Parents in the intervention group had a significant decrease in PACV score at 2 months compared to control (median difference 6.7, P = .049); this remained significant after adjustment for baseline PACV score, race/ethnicity, and income (P = .044). There was no difference in the on-time receipt of vaccines between groups at 12 weeks. CONCLUSIONS: A brief educational intervention for vaccine-hesitant parents was associated with a modest but significant increase in measured parental attitudes toward vaccines.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Jason M Glanz; Sophia R Newcomer; Komal J Narwaney; Simon J Hambidge; Matthew F Daley; Nicole M Wagner; David L McClure; Stan Xu; Ali Rowhani-Rahbar; Grace M Lee; Jennifer C Nelson; James G Donahue; Allison L Naleway; James D Nordin; Marlene M Lugg; Eric S Weintraub Journal: JAMA Pediatr Date: 2013-03-01 Impact factor: 16.193
Authors: Deborah A Gust; Tara W Strine; Emmanuel Maurice; Philip Smith; Hussain Yusuf; Marilyn Wilkinson; Michael Battaglia; Robert Wright; Benjamin Schwartz Journal: Pediatrics Date: 2004-07 Impact factor: 7.124
Authors: Rachel M Cunningham; G Brady Kerr; Jessica Orobio; Flor M Munoz; Armando Correa; Natalie Villafranco; Ana C Monterrey; Douglas J Opel; Julie A Boom Journal: Hum Vaccin Immunother Date: 2019-03-27 Impact factor: 3.452
Authors: Douglas J Opel; Nora Henrikson; Katherine Lepere; Rene Hawkes; Chuan Zhou; John Dunn; James A Taylor Journal: Pediatrics Date: 2019-10-09 Impact factor: 7.124